Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Alnylam's siRNA duplexes silence gene involved in hypercholesterolemia

Aug. 30, 2005

APD-356 shows no apparent effect on heart valves or pulmonary artery pressure

Aug. 29, 2005

New investment supports 7TM's metabolic disorders programs

Aug. 29, 2005

BMS describes novel agents for osteoporosis, among other indications

Aug. 25, 2005

CL-316243/oleoyl-estrone shows promise for obesity

Aug. 24, 2005

Biovitrum and Santhera sign license agreement for DPP-IV program

Aug. 23, 2005

Companies disclose new treatments for diabetes

Aug. 23, 2005

Novel agents for treating eating disorders claimed by sanofi-aventis

Aug. 23, 2005

Stat3 identified as a novel target for contraception

Aug. 23, 2005

Oral contraceptive Yasminelle approved in Netherlands

Aug. 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...